Metabolic pathways of inhaled glucocorticoids by the CYP3A enzymes.
about
Dosing Recommendations for Concomitant Medications During 3D Anti-HCV TherapyUtilization of inhaled corticosteroids for infants with bronchopulmonary dysplasiaMetabolic profiling of tenacigenin B, tenacissoside H and tenacissoside I using UHPLC-ESI-Orbitrap MS/MS.Metabolism of beclomethasone dipropionate by cytochrome P450 3A enzymesLong-Term Fluticasone Propionate/Formoterol Fumarate Combination Therapy Is Associated with a Low Incidence of Severe Asthma Exacerbations.Regulation of CYP3A genes by glucocorticoids in human lung cellsMetabolic considerations of drugs in the treatment of allergic diseases.Flunisolide for the treatment of asthma.Cytochrome P450 interactions and clinical implication in rheumatology.Inhaled corticosteroids and HPA axis suppression: how important is it and how should it be managed?Genetic variation in the glucocorticoid pathway involved in interindividual differences in the glucocorticoid treatment.Pharmacokinetics of Budesonide Administered with Surfactant in Premature Lambs: Implications for Neonatal Clinical Trials.Antiinflammatory Effects of Budesonide in Human Fetal Lung.Detection and characterization of triamcinolone acetonide metabolites in human urine by liquid chromatography/tandem mass spectrometry after intramuscular administration.Predicting anxiety responses to halogenated glucocorticoid drugs using the hexobarbital sleep time test.Simultaneous Determination of Formoterol Fumarate and Budesonide Epimers in Metered Dose Inhaler Using Ion-Pair Chromatography.NR3C1 gene polymorphisms are associated with steroid resistance in patients with primary nephrotic syndrome.Effects of budesonide and surfactant in preterm, fetal sheep.
P2860
Q28080752-73999EFC-FA90-4867-A7D3-E312FE36D0C4Q28542831-8EB611C4-88E9-4DD6-9FA0-A839DE290307Q35997231-E7504C94-FCFA-4A43-B374-DCB42CBA3B68Q36776572-2C9B8D80-3325-4ABB-9F78-AB85DADB9A45Q37137128-6CA93FA4-A2C6-4D01-9917-1044112F035AQ37406800-3921D5E2-5F1D-4E41-B03E-25AB52CD549EQ38125525-5C31780F-D892-44AA-AAC5-58E9A2708BE5Q38203322-4F87CED9-C16D-420B-932E-9C55031A1793Q38219868-50A51235-13DF-4DE5-A57E-9A5E6916B0D6Q38796254-A9E08CFF-80EF-411D-971F-D5451C66BE6DQ39098740-3C143669-5673-4046-9B12-03E19C841643Q40489148-A7F4C472-4AF1-45E9-BCA1-76344E996384Q40505997-4E1153CE-4FC3-4EAA-99AA-76533C8F5F65Q41624660-88BAC829-1BE6-4111-B6AF-646BFCFE845CQ47430326-0CCC47DF-B8A3-4EBC-8257-BAF2E6048C09Q49608204-526EDE1B-DFD8-41A3-96B5-E33BF5572075Q50062062-0B5908C9-82A1-41D4-9EF0-E47BDBFB527FQ52718375-D7B369C2-03BA-4B0D-83BC-54D33B87AC48
P2860
Metabolic pathways of inhaled glucocorticoids by the CYP3A enzymes.
description
2012 nî lūn-bûn
@nan
2012 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Metabolic pathways of inhaled glucocorticoids by the CYP3A enzymes.
@ast
Metabolic pathways of inhaled glucocorticoids by the CYP3A enzymes.
@en
Metabolic pathways of inhaled glucocorticoids by the CYP3A enzymes.
@nl
type
label
Metabolic pathways of inhaled glucocorticoids by the CYP3A enzymes.
@ast
Metabolic pathways of inhaled glucocorticoids by the CYP3A enzymes.
@en
Metabolic pathways of inhaled glucocorticoids by the CYP3A enzymes.
@nl
prefLabel
Metabolic pathways of inhaled glucocorticoids by the CYP3A enzymes.
@ast
Metabolic pathways of inhaled glucocorticoids by the CYP3A enzymes.
@en
Metabolic pathways of inhaled glucocorticoids by the CYP3A enzymes.
@nl
P2093
P2860
P356
P1476
Metabolic pathways of inhaled glucocorticoids by the CYP3A enzymes.
@en
P2093
Chad D Moore
Christopher A Reilly
Christopher R Orton
Garold S Yost
Jessica K Roberts
Robert M Ward
Takahiro Murai
Trevor P Fidler
P2860
P304
P356
10.1124/DMD.112.046318
P577
2012-11-09T00:00:00Z